Author:
Ruhé Henricus G.,Frokjaer Vibe G.,Haarman Bartholomeus C. M.,Jacobs Gabriël E.,Booij Jan
Publisher
Springer International Publishing
Reference521 articles.
1. Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ (2012) Ketamine for depression: where do we go from here? Biol Psychiatry 72:537–547
2. Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P (2012) Depression in Parkinson disease—epidemiology, mechanisms and management. Nat Rev Neurol 8:35–47
3. van der Aart J, Golla SSV, van der Pluijm M, Schwarte LA, Schuit RC, Klein PJ, Metaxas A, Windhorst AD, Boellaard R, Lammertsma AA, van Berckel BNM (2018) First in human evaluation of [18F]PK-209, a PET ligand for the ion channel binding site of NMDA receptors. EJNMMI Res 27:69
4. van der Aart J, Yaqub M, Kooijman EJM, Bakker J, Langermans JAM, Schuit RC, Hofman MB, Christiaans JA, Lammertsma AA, Windhorst AD, van Berckel BNM (2019) Evaluation of the novel PET tracer [11C]HACH242 for imaging the GluN2B NMDA receptor in non-human primates. Mol Imaging Biol 21:676–685
5. Acton PD, Choi SR, Hou C, Plossl K, Kung HF (2001) Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT. J Nucl Med 42:1556–1562